Table 3.
Characterization of virulence profiles of community- and hospital-acquired UTI K. pneumoniae isolates.
| Nr. of Virulence Genes | Virulence Profile (VP) | Virulence Genes | Nr. Isolates (%) | ||
|---|---|---|---|---|---|
| CA-UTI n = 50 (100) |
HA-UTI n = 31 (100) |
Total n = 81 (100) |
|||
| 0 VF | 1 | No VF | 8 (16.0) | 0 | 8 (9.9) |
| 1 VF | 2 | khe | 5 (10.0) | 0 | 5 (6.2) |
| 3 | fimH | 1 (2.0) | 0 | 1 (1.2) | |
| 4 | mrkDV1 | 2 (4.0) | 0 | 2 (2.5) | |
| 5 | mrkDV2-4 | 3 (6.0) | 0 | 3 (3.7) | |
| 2 VF | 6 | fimH, khe | 2 (4.0) | 2 (6.3) | 4 (4.9) |
| 7 | fimH, mrkDV1 | 0 | 3 (9.4) | 3 (3.7) | |
| 8 | khe, iucC | 1 (2.0) | 0 | 1 (1.2) | |
| 9 | iucC, mrkDV2-4 | 2 (4.0) | 0 | 2 (2.5) | |
| 10 | khe, mrkDV1 | 2 (4.0) | 0 | 2 (2.5) | |
| 11 | khe, mrkDV2-4 | 5 (10.0) | 0 | 5 (6.2) | |
| 12 | fimH, mrkDV2-4 | 5 (10.0) | 0 | 5 (6.2) | |
| 13 | fimH, khe, mrkDV1 | 2 (4.0) | 13 (40.6) | 15 (18.5) | |
| 14 | fimH, khe, iucC | 1 (2.0) | 0 | 1 (1.2) | |
| 15 | fimH, khe, mrkDV2-4 | 2 (4.0) | 0 | 2 (2.5) | |
| 3 VF | 16 | fimH, iucC, mrkDV1 | 2 (4.0) | 1 (3.1) | 3 (3.7) |
| 17 | fimH, iucC, mrkDV2-4 | 4 (8.0) | 0 | 4 (4.9) | |
| 18 | khe, mrkDV1, iucC | 0 | 1 (3.1) | 1 (1.2) | |
| 19 | K2, khe, mrkDV1 | 2 (4.0) | 0 | 2 (2.5) | |
| 20 | K2, fimH, mrkDV1 | 0 | 1 (3.1) | 1 (1.2) | |
| 21 | K2, fimH, khe, mrkDV2-4 | 1 (2.0) | 0 | 1 (1.2) | |
| 4 VF | 22 | K2, fimH, khe, mrkDV1 | 0 | 7 (21.9) | 7 (8.6) |
| 23 | fimH, khe, mrkDV1, iucC | 0 | 2 (6.3) | 2 (2.5) | |
| 5 VF | 24 | K2, fimH, khe, mrkDV1, iucC | 0 | 1 (3.1) | 1 (1.2) |
Legend: VF, virulence factor; VP, virulence profile; CA-UTI, community-acquired urinary tract infection; HA-UTI, hospital-acquired urinary tract infection.